Trihydroxycholanoyl‐taurine in brains of rodents with hepatic encephalopathy. (3rd May 2021)

• Record Type: Journal Article
• Authors: Schnelle, Amy N. W.; Richardson, Luke T.; Pettit, Michael E.; DeMorrow, Sharon; Solouki, Touradj
• Is Part Of: Journal of mass spectrometry. Volume 56:Number 6(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-05-03
• Subjects: brain -- hepatic encephalopathy -- mass spectrometry -- taurocholic acid -- trihydroxycholanoyl‐taurine; Mass spectrometry -- Periodicals; 543.65
• DOI: 10.1002/jms.4729
• Languages: English
• ISSNs: 1076-5174

Abstract

Abstract: Hepatic encephalopathy (HE), a neurological disease resulting from liver failure, is difficult to manage and its causes are unclear. Bile acids have been postulated to be involved in the provenance and progression of various diseases including HE. Hence, the characterization of bile acid profiles in the brains of subjects with and without liver failure can provide important clues for the potential treatment of HE. Nanoflow ultra‐performance liquid chromatography electrospray ionization ion mobility mass spectrometry (UPLC‐ESI‐IM‐MS) is a highly sensitive method for detection of specific molecules, such as bile acids in brain samples, at biologically relevant concentrations. We used UPLC‐ESI‐IM‐MS to characterize bile acid profiles in brain samples from seven "healthy" control rodents and 22 "diseased" rodents with liver failure (i.e., induced HE). An isomer of trihydroxycholanoyl‐taurine was detected in brain tissue samples from both rats and mice with induced HE; however, this isomer was not detected in the brains of healthy rats and mice. Our findings were confirmed by comparing IM arrival times (AT), exact mass measurements ( m/z ), and mass spectral fragmentation patterns of the experimentally observed suspected species to standards of trihydroxycholanoyl‐taurine isomers. Moreover, In Silico Fractionation was employed to provide an additional analytical dimension to verify bile acid identifications.